This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 4238196

PUBLISHED DESCRIPTION

591009.18

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Évora, Évora
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
- - NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA
Awardee
MERCK SHARP & DOHME, LDA · Tax ID 500191360
Awardee
- - MEDAC
Awardee
HIKMA FARMACEUTICA (PORTUGAL),LDA · Tax ID 502266791
Awardee
MERCK, S.A. · Tax ID 500650870
Awardee
ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
Awardee
BIOGEN IDEC PORTUGAL · Tax ID 506415740
Awardee
ASTRAZENECA-PRODUTOS FARMACÊUTICOS,LDA. · Tax ID 502942240
Awardee
AbbVie, LDA · Tax ID 510229050
Awardee
ACCORD HEALTHCARE, UNIPESSOAL, LDA · Tax ID 508622263
Awardee
ASTELLAS FARMA LDA · Tax ID 502540249

HOW MUCH AND WHEN

Values and timeline

Contract price
€2,636,007.33
Procedure base price
€3,031,990.02
Total effective price
Not reported on Portal BASE
Publication date
12 February 2018
Award date
28 December 2017
Signing date
28 December 2017
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Not stated
CPV code
33652000-5 - Antineoplásicos e imunomoduladores
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL 18/2008)
Framework agreement
CP2015-06 Medicamentos do foro oncologico SPMS - P259-AC-2016-174
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
3255457

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts